Previous 10 | Next 10 |
2023-10-03 18:33:22 ET Eli Lilly 's (NYSE: LLY) latest acquisition didn't exactly meet with widespread shareholder approval on Tuesday. After announcing that it signed a deal to acquire Point Biopharma Global (NASDAQ: PNT) , its share price headed south to end the day 2.4% l...
2023-10-03 13:52:18 ET Shares of Point Biopharma Global (NASDAQ: PNT) were up by more than 85% as of 11:45 a.m. ET on Tuesday after the healthcare company entered into a buyout agreement. The stock is up more than 70% this year. Point Biopharma is a clinical-stage company th...
2023-10-03 13:32:22 ET Summary Eli Lilly's acquisition of POINT Biopharma Global strategically boosts its portfolio in radiopharmaceuticals, with immediate late-stage clinical assets and manufacturing capabilities. POINT Biopharma's financial health is stable with a 27-month cash ...
2023-10-03 12:12:51 ET DENVER, Colo., Oct 3, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; ALX Oncology Holdings (NASDAQ: ALXO), POINT Biopharma Global (NASDAQ: PNT), SciSparc (NASD...
2023-10-03 10:29:23 ET Shares of Point Biopharma Global Inc (NASDAQ: PNT) close to doubled this morning after Eli Lilly & Co (NYSE: LLY) announced plans of acquiring the cancer treatment company. Details of Lilly-Point agreement Lilly is willing to pay about $1.4 billion for...
2023-10-03 09:59:26 ET DENVER, Colo., Oct 3, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ALX Oncology Holdings (NASDAQ: ALXO), POINT Biopharma Global (NASDAQ: PNT), SciSparc (NASDAQ: SPRC), ODDITY Tec...
2023-10-03 08:37:00 ET U.S. stock index futures on Tuesday pointed to a lower open, as longer-end Treasury yields surged amid a bruising bond sell-off. Market participants will also be receiving data on the labor market in the form of the Job Openings and Labor Turnover Survey (JOLTS). ...
2023-10-03 07:17:09 ET More on POINT Biopharma POINT Biopharma: Leading The Future Of Radioligand Therapy POINT Biopharma: Stock Has Upcoming Catalysts With 2 Therapies In Phase 3 Trials POINT Biopharma slips after pipeline update Seeking Alpha’s Quant...
Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies PR Newswire INDIANAPOLIS , Oct. 3, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and POINT Biopharma Global, Inc. (NASDAQ: PNT) today an...
INDIANAPOLIS and SCHLIEREN-ZURICH, Switzerland, Sept. 18, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, and Athe...
News, Short Squeeze, Breakout and More Instantly...
POINT Biopharma Global Inc. Company Name:
PNT Stock Symbol:
NASDAQ Market:
NORTHAMPTON, MA / ACCESSWIRE / June 25, 2024 / Pentair Greg Claffey, Group President, Pentair Pool (right) presents Pentair Pool Step Into Swim sponsorship check to Rowdy Gaines, Vice President Partnerships and Development, PHTA, and Olympic Gold Medalist. As published on the Pentair Blog . ...
LONDON, UK / ACCESSWIRE / April 18, 2024 / Pentair plc (NYSE:PNR), a leader in helping the world sustainably move, improve and enjoy water, life's most essential resource, today released its 2023 Corporate Responsibility Report, reporting on the Company's efforts and progress toward Making Bett...
Lilly Completes Acquisition of POINT Biopharma PR Newswire INDIANAPOLIS , Dec. 27, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of POINT Biopharma Global Inc. (NASDAQ: PNT), a radiopharmaceuti...